Our Partner Organisations
The Psychiatry Consortium have partnered with two leading drug discovery organisations, to provide projects with specialized drug-discovery know-how and hands-on research support required to take projects through to completion. Wellcome provides grant funding to support the Psychiatry Consortium’s academic outreach activities.
Charles River Laboratories
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. Charles River offers a wide range of products and services that span the entire drug discovery and development continuum and can be tailored to specific research conditions.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches. The Company provides drug discovery solutions in form of integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates and fee-for-service work. With more than 2,100 employees across 13 sites, Evotec operates worldwide and has key therapeutic expertise in the areas of neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, fibrosis, respiratory and infectious diseases. By leveraging this expertise, Evotec intends to develop best-in-class and first-in-class differentiated therapeutics on its systematic, unbiased and comprehensive infrastructure.
Wellcome is an independent global charitable foundation, that exists to improve health by helping great ideas to thrive. They support researchers, take on big health challenges, campaign for better science, and help everyone get involved with science and health research. Wellcome is providing grant funding to support the Psychiatry Consortium’s academic outreach activities.